Bio Green Med Solution, Inc.

BGMS Industrials Building Products & Equipment

Bio Green Med Solution, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747,000.00, up 1,637.2% from fiscal 2024.

Revenue
+3,260.0%
EPS
+91.8%
Free cash flow
+66.7%

Quarter to June 2026, against a year earlier

0.86 0.01 −1.15%
Market cap
$5.7M
P/E
0.0×
Fwd P/E
−0.3×
Dividend yield
0.00%
F-score
4/9
Altman Z
−78.86
Beneish M
n/a
Dividend safety
n/a

Bio Green Med Solution, Inc. (BGMS) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Bio Green Med Solution, Inc. (BGMS) trades at a EV/Sales of 0.6×. Over the past ten years it has ranged from −26.0× (June 2025) to 18,487,767× (March 2015); the current reading is higher than 67% of that period. That is below the Building Products & Equipment industry median of 2.3× and below the Industrials sector median of 1.8×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 5.3× (4.29%)
FY2024 5.6× —
FY2023 −1.7× —
FY2018 −10.4× —
FY2016 −19.6× —
FY2015 −10.5× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 0.7× (49.23%)
Mar 2026 1.4× (74.03%)
Dec 2025 5.3× (88.25%)
Sep 2025 45.2× (56.17%)
14 more quarters

Against its own ten years

Low −26.0× High 18,487,767×
Ten-year median −4.7×
Current reading's percentile 6

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on BGMS